Bioruptor Plus Sonication Device
Waiver type - Procurement: Nonavailability
Agency: NATIONAL INSTITUTES OF HEALTH (7529) • Product Service Code (PSC) : 6640 | Last Modified: 09/18/2024
Procurement Summary
The National Institutes of Health (NIH), National Cancer Institute (NCI), Laboratory of Biochemistry and Molecular Biology (LBMB) in the Center for Cancer Research (CCR) investigates basic mechanisms underlying cell growth, division, differentiation, and homeostasis, with a focus on the biology of chromosomes and the cell nucleus. LBMB requires one (1) Bioruptor Plus Sonication Device to meet this need.
Waiver Rationale Summary
Laboratory of Biochemistry and Molecular Biology (LBMB) routinely performs protocols that require disruption/breakage of cells and shearing of chromatin into smaller pieces. Previously, LBMB used a Bioruptor Plus machine to conduct biochemistry experiments and have come to rely on it quite heavily for cell disruption and shearing chromatin, RNA, and DNA that support a variety of techniques including ChIP-seq and genome-wide sequencing library preparation. A combined synopsis/ solicitation was posted on SAM.gov from August 13, 2024 to August 22, 2024. Only one response was received from Diagenode. The bioruptor plus sonication device is not mined, produced, or manufactured in the United States in sufficient and reasonably available commercial quantities and of a satisfactory quality.
Yes
Yes
Consistent with Policy
LABORATORY EQUIPMENT AND SUPPLIES
334516 - Analytical Laboratory Instrument Manufacturing
08/27/2024
75N91024Q00168
75N91024Q00168
Post-solicitation
Instant Delivery Only
Individual Waiver
NATIONAL INSTITUTES OF HEALTH